Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer

Date

2016

Author

Salman, Tarık
Bilici, Ahmet
Arslan, Çağatay
Varol, Umut
Yıldız, İbrahim
Akyol, Murat
Yıldız, Yaşar
Küçükzeybek, Yüksel
Alacacıoğlu, Ahmet
Yılmaz, Uğur

Metadata

Show full item record

Citation

Salman, T., Bilici, A., Arslan, Ç., Varol, U., Yıldız, İ., Akyol, M. ... Yılmaz, U. (2016). Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer. Gastrointestinal Cancers Symposium. San Francisco, California, January 21-23, 2016. https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615

Abstract

...

Source

Gastrointestinal Cancers Symposium

Volume

34

Issue

4

URI

https://dx.doi.org/10.1200/jco.2016.34.4_suppl.615
https://hdl.handle.net/20.500.12511/5719

Collections